Physician profile
Michael Diaz
NPI 1295748176
$3,442.00
in general payments reported to CMS, 2019-2025
15 companies · $321 in 2025
The $321 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,603 · 2020: $99.54 · 2021: $111 · 2022: $565 · 2023: $377 · 2024: $365 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,273.87 | 2019-2022 | |
| Atricure, INC. | $567.02 | 2022-2023 | |
| Mentor Worldwide LLC | $427.44 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Abbott Laboratories | $293.80 | 2019 | |
| Motiva USA, LLC | $278.51 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $166.62 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $140.03 | 2019-2025 | Opdivo |
| Galderma Laboratories, L.P. | $98.05 | 2019-2024 | |
| Medline Industries Lp | $34.11 | 2021-2022 | |
| Organogenesis INC. | $32.32 | 2023 | Puraply |
| Merz North America, INC. | $30.87 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $29.41 | 2024 | Iovera, Exparel |
| Abbvie INC. | $25.17 | 2024 | |
| Foundation Medicine, INC. | $23.01 | 2023 | |
| Sientra, INC. | $21.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.